ASTS
AST SpaceMobile, Inc.
ASTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
POET
POET Technologies Inc.
There isn't enough reported data to score POET yet.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
POET Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Unavailable |
POET's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
POET PE Valuation
POET has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
POET Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect POET's revenue to grow, with its earnings and profitability holding steady. However, they disagree widely on these estimates.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS has the edge over POET on earnings, with more consistent year-over-year improvement.
POET Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.71 | +$0.04 |
| Q1 2026 | -$0.85 | -$0.17 |
| Q4 2025 | -$0.69 | +$0.19 |
| Q3 2025 | -$0.65 | -$0.06 |
| Q2 2025 | -$0.75 | -$0.23 |
| Q1 2025 | -$0.68 | -$0.19 |
| Q4 2024 | -$0.88 | -$0.38 |
| Q3 2024 | -$0.59 | -$0.05 |
POET is still losing money, but less than at its worst: $0.71 per share over the past year, against $0.88 at its worst in late 2024.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over POET on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS has the edge over POET on profitability, with a higher operating margin.
POET Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $569.9K | +112% |
| Q1 2026 | $503.4K | +202% |
| Q4 2025 | $341.2K | +1075% |
| Q3 2025 | $298.4K | +7999% |
| Q1 2025 | $166.8K | +1823% |
| Q4 2024 | $29K | -73% |
| Q1 2024 | $8.7K | -95% |
| Q4 2023 | $107.6K | -46% |
POET's revenue has grown year over year for six quarters in a row: $569,925 last quarter, up 112% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -3543% | -281 points |
| Q1 2026 | -3550% | +2169 points |
| Q4 2025 | -2817% | +36594 points |
| Q3 2025 | -3202% | +179880 points |
| Q2 2025 | -3262% | N/A |
| Q1 2025 | -5719% | +53055 points |
| Q4 2024 | -39411% | N/A |
| Q3 2024 | -183082% | N/A |
POET's operating margin was โ3543% last quarter, down 281 points from the same quarter a year ago.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: โ$1.8B over the past year, against โ$916M the year before.
POET Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$15.2M | -$5.3M |
| Q1 2026 | -$11.2M | -$1.7M |
| Q4 2025 | -$10.9M | +$1.8M |
| Q3 2025 | -$3.2M | +$3.4M |
| Q2 2025 | -$9.9M | -$3.5M |
| Q1 2025 | -$9.5M | -$4.8M |
| Q4 2024 | -$12.7M | -$9.7M |
| Q3 2024 | -$6.5M | -$1.4M |
POET has the edge over ASTS on cash flow, with more consistent year-over-year improvement.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
POET Net Leverage
POET's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
POET Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.0 | Neutral |
| Stochastic | 14.3 | Oversold |
POET's weekly RSI is 39 (neutral) and its Stochastic is 14 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
POET PE vs Technology Sector
POET has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
POET Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.11 | 15% below |
| 20 week MA | $7.26 | 28% below |
| 50 week MA | $7.94 | 34% below |
| 100 week MA | $6.52 | 20% below |
| 200 week MA | $4.77 | 9.2% above |
POET has fallen below most of its moving averages, though it's still 9.2% above its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to โ54% in 2022. It's down 52% so far in 2026.
POET Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.70 | $6.10 | +126% |
| 2021 | $6.10 | $6.90 | +13% |
| 2022 | $6.90 | $2.97 | -57% |
| 2023 | $2.97 | $0.94 | -68% |
| 2024 | $0.94 | $6.96 | +640% |
| 2025 | $6.96 | $6.81 | -2.2% |
| 2026 YTD | $6.81 | $5.21 | -23% |
POET has the edge over ASTS on returns for 2026, with the stronger performance.